Donald J. Griffith - 09 Dec 2022 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Director
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
09 Dec 2022
Net transactions value
-$518
Form type
4
Filing time
17 Feb 2023, 15:43:55 UTC
Previous filing
08 Apr 2022
Next filing
05 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +3,214 +42% 10,798 09 Dec 2022 Direct F1, F2
transaction SONN Common Stock Tax liability $518 -497 -4.6% $1.04 10,301 06 Feb 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 9, 2022, the Reporting Person was granted 3,214 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
F2 Includes unvested restricted stock units.